AUSTRALIA:
The Therapeutic Goods Administration said on Wednesday a link between the vaccine and clot disorders had not been proven but that it was still investigating the issue as vaccinations continue.
BULGARIA:
Resumed inoculations from March 19.
CYPRUS:
Cyprus, which suspended the vaccine on March 15, resumed inoculations on March 19.
CANADA:
To pause offering vaccine to people aged under 55 and require a new analysis of the shot’s benefits and risks based on age and gender.
FRANCE:
Medical regulator approved the resumed use of AstraZeneca’s vaccine on March 19, but said it should only be given to people aged 55 and older.
FINLAND:
Resumed using the AstraZeneca vaccine from March 29, but will only give it to people aged 65 and over.
GEORGIA:
Has limited the use of the vaccine after a nurse died of anaphylactic shock, and vaccinations will continue only in full-fledged medical centers, news agency TASS reported on March 19.
GERMANY:
From March 31, Germany will limit use of the shot to people over 60 years and high-priority groups, following further reports of a rare brain blood disorder.
ICELAND:
Resumed use on March 25 after suspending it on March 11 pending investigations into reports that it might be linked to blood clots.
INDONESIA:
Resumed using the vaccine on March 22 but warned against the use of the vaccine in people with a low blood platelet count.
IRELAND:
Plans to resume rollout of the vaccine for all those aged 18 and over in ‘the coming days,’ a committee said on March 19, after suspending it on March 14.
ITALY:
Resumed using the vaccine on March 19, and Italians who decline to be inoculated with it will be given an alternative later on.
LATVIA:
Also said it would restart administering the shots from March 19.
LITHUANIA:
Restarted administering the vaccine on March 19, currently for over 65-year-olds only.
NETHERLANDS:
The health minister said on March 18 that the country would resume using the vaccine that week.
NORTH MACEDONIA:
Health Minister Venko Filipce said on March 31 that AstraZeneca shots would be limited to people aged over 60 as a precautionary measure.
SOUTH KOREA:
President Moon Jae-in received the vaccine on March 23 ahead of an overseas trip, as the country inoculates senior citizens and health workers.
SPAIN:
Spain said on March 30 it would use the vaccine for people aged 55-65, and a day later said it would extend the vaccination to essential workers over 65 years old.
SWEDEN:
Resumed use of the vaccine on March 25 for people aged 65 and older, its health agency said, but restrictions are in place for Swedes under 65 years.
THAILAND:
Began use on March 15, with Prime Minister Prayuth Chan-ocha becoming the first to be inoculated, after Thailand delayed rollout the week before.
VACCINE USE SUSPENDED
AUSTRIA:
Suspended use of one batch of the vaccine on March 7 after the death of one person and the illness of another.
CAMEROON:
Suspended administration of the vaccine it was scheduled to receive on March 20 as part of the global vaccines sharing scheme COVAX, the health ministry said.
DENMARK:
Will prolong its suspension of the shot by three weeks pending further investigations after its two-week pause ended on March 25. A local survey indicated that one in three Danes would decline to get the shot.
NORWAY:
Norway will delay a decision over the use of the vaccine, authorities said on March 26, with a decision expected by April 15.
ROMANIA:
Temporarily stopped vaccinating people with one batch of the vaccine on March 11.
SOURCE: REUTERS